# SandboxAQ

> SandboxAQ builds enterprise quantitative AI and advanced sensing software for drug discovery, materials development, cryptographic security and navigation without GPS. Its Large Quantitative Models combine scientific data, physics-based simulation and machine learning, with products sold through enterprise engagements and cloud or AI-platform channels.

- **Founded:** 2022
- **Headquarters:** Palo Alto, United States
- **Founders:** Jack Hidary (Founder and CEO)
- **Products:** ReAQT, AQBioSim, AQChemSim, AQCat, AQPotency
- **Notable:** Emerged independently from Alphabet in March 2022., Acquired Cryptosense in September 2022 and Good Chemistry in January 2024., Reported more than $950 million raised since spinout at the April 2025 Series E close.

## Products & services

- **ReAQT** — AI simulation platform combining physics-grounded data generation, Large Quantitative Models and discovery workflow orchestration.
- **AQBioSim** — Drug discovery capabilities spanning virtual screening, molecular design, binding affinity and lead optimization.
- **AQChemSim** — AI and computational chemistry capabilities for chemical and materials discovery.
- **AQCat** — Catalyst-property prediction model, generally available through Claude and AWS Marketplace in August 2026.
- **AQPotency** — Structure-free compound-target potency ranking with uncertainty and applicability signals; launched August 2026 and added AWS availability in October.
- **AQAffinity** — Open-source binding-affinity prediction built on OpenFold3.
- **AQtive Guard** — Enterprise cryptography management and security platform; expanded into AI security posture management with an early-access announcement in December 2025.
- **AQNav** — Magnetic navigation software using magnetometer and inertial data to support positioning when GPS is unavailable.
- **CardiAQ / AQMed** — Magnetocardiography research and cardiac sensing program, including announced Mayo Clinic collaboration; clinical research is distinct from marketing authorization.
- **QEMIST Cloud and Tangelo** — Computational chemistry platform and open-source quantum chemistry SDK acquired with Good Chemistry.

## Achievements

- Emerged independently from Alphabet in March 2022.
- Acquired Cryptosense in September 2022 and Good Chemistry in January 2024.
- Reported more than $950 million raised since spinout at the April 2025 Series E close.
- Released AQCat25 publicly in September 2025 after more than 400,000 GPU-hours of data generation.
- Made AQCat and AQPotency available through commercial AI or cloud channels in 2026.
- Announced AQNav testing with Northrop Grumman in September 2026.

## Latest updates

- **2026-06** — Signed a definitive $500 million CHIPS R&D award agreement with Commerce for critical semiconductor-related materials.
- **2026-08** — Launched AQPotency and announced general availability of AQCat through Claude and AWS channels.
- **2026-09** — Announced successful AQNav flight testing on Northrop Grumman’s Lumberjack platform.
- **2026-10** — October 6: AQPotency became generally available through AWS Marketplace and Amazon SageMaker.

## Links

- Website: https://www.sandboxaq.com/
- LinkedIn: https://www.linkedin.com/company/sandboxaq
- Twitter/X: https://twitter.com/sandboxaq
- GitHub: https://github.com/sandbox-quantum
- YouTube: https://www.youtube.com/@sandboxaq

---

Profile page: https://yespress.io/sandboxaq
Published by YesPress — https://yespress.io
Last updated: 2026-10-25